Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Capital Leases: 2011-2023

Historic Capital Leases for Niagen Bioscience (NAGE) over the last 9 years, with Dec 2023 value amounting to $12,000.

  • Niagen Bioscience's Capital Leases fell 85.71% to $2,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $2,000, marking a year-over-year decrease of 85.71%. This contributed to the annual value of $12,000 for FY2023, which is 45.45% down from last year.
  • Latest data reveals that Niagen Bioscience reported Capital Leases of $12,000 as of FY2023, which was down 45.45% from $22,000 recorded in FY2022.
  • Niagen Bioscience's 5-year Capital Leases high stood at $22,000 for FY2022, and its period low was $12,000 during FY2023.
  • In the last 2 years, Niagen Bioscience's Capital Leases had a median value of $17,000 in 2022 and averaged $17,000.
  • Its Capital Leases has fluctuated over the past 5 years, first slumped by 86.86% in 2019, then increased by 11.11% in 2020.
  • Over the past 4 years, Niagen Bioscience's Capital Leases (Yearly) stood at $18,000 in 2019, then climbed by 11.11% to $20,000 in 2020, then reached $22,000 in 2022, then slumped by 45.45% to $12,000 in 2023.